FIELD: medicine, pharmaceutical industry, pharmacy. SUBSTANCE: invention relates to the development of novel medicinal forms containing human leucocyte interferon. Tablet for oral use has the purified and concentrated leucocyte interferon with activity 2000-20000 IU and powder-like filling agent taken in the definite ratio of components. Invention provides the enhanced effectiveness of topical effect of administrated interferon dose on clinical process, the preparation does not induce nonfavorable effects and devoids of defects of injection forms. EFFECT: improved properties, enhanced effectiveness of preparation. 2 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DETERMINATION OF INTERFERON ANTIVIRAL ACTIVITY IN SOFT MEDICINAL FORMS | 1995 |
|
RU2123351C1 |
| OINTMENT WITH HUMAN LEUKOCYTIC INTERFERON "INTERON" | 1997 |
|
RU2141819C1 |
| SUPPOSITORY | 1996 |
|
RU2119330C1 |
| SUBLINGUAL TABLET MEDICINAL PREPARATION COMPRISING ALPHA- INTERFERON AND METHOD FOR ITS PREPARING | 2003 |
|
RU2234939C1 |
| SUCKING PILL CONTAINING HUMAN INTERFERON AND/OR INTERFERON INDUCTOR POSSESSING ANTIVIRAL ACTIVITY | 2004 |
|
RU2277932C2 |
| METHOD OF DETERMINATION OF ACTIVE SUBSTANCE IN DIPHILIC OINTMENT BASES | 1998 |
|
RU2148396C1 |
| METHOD OF PREPARING THE ENTERAL PREPARATION CONTAINING ALPHA-INTERFERON AND ENTERAL PREPARATION CONTAINING ALPHA-INTERFERON AS TABLETS | 1993 |
|
RU2083222C1 |
| STABILIZED COMPOSITION POSSESSING ANTIVIRAL, ANTICANCER, IMMUNOMODULATORY, ACTOPROTECTIVE, ANTIMUTAGENIC AND ANTIOXIDANT ACTIVITY | 2018 |
|
RU2690677C1 |
| ENTERAL PREPARATION THAT CONTAINS BIOMASS EXTRACT OF RED CALIFORNIAN DEW WORM MANUFACTURED AS VERMIN TABLETS | 1999 |
|
RU2177784C2 |
| COMPOSITION POSSESSING ANTIVIRAL AND ANTIBACTERIAL EFFECT | 2006 |
|
RU2292907C1 |
